PDS Biotechnology Corporation (PDSB) Stock: Here’s Why It’s Down


PDS Biotechnology Corporation (PDSB) is falling in the market today. The stock, focused on the biotech sector, is presently trading at $7.74 after tumbling -10.83% so far in today’s session. When it comes to biotech stocks, there are a number of factors that have the ability to cause price movement in the market. One of the most common is news. Here are the most recent stories surrounding PDSB:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

May-15-19 08:30AM PDS Biotechnology Announces Publication Supporting Novel Mechanisms of Action of its Proprietary Versamune® Platform in Cancer Immunotherapy
May-14-19 05:22PM PDS Biotechnology: 1Q Earnings Snapshot
04:10PM PDS Biotechnology Reports First Quarter 2019 Financial Results and Provides Business Update
Apr-08-19 08:00AM PDS Biotechnology Appoints Stephen Glover to its Board of Directors
May-15-19 08:30AM PDS Biotechnology Announces Publication Supporting Novel Mechanisms of Action of its Proprietary Versamune® Platform in Cancer Immunotherapy

However, when making a decision to invest, investors should look at far more than news, this is especially the case in the speculative biotechnology space. Here’s what’s happening in regard to PDS Biotechnology Corporation.

Returns That PDSB Investors Have Seen

While a decline in a single session, like the move that we’re seeing from PDS Biotechnology Corporation might lead to fear in some investors, a single session move by itself shouldn’t be the reason for a decision to, or not to, invest in a stock. It is always important to look at trends experienced by the stock further out than a single trading session. In the case of PDSB, below are the trends that we’ve seen:

  • Past Seven Days – Throughout the past five trading sessions, PDSB has produced a price change amounting to 28.59%.
  • Past Month – The monthly performance from PDS Biotechnology Corporation has been 36.69%.
  • Past 3 Months – Over the last three months, the company has produced a return that works out to 5.60%
  • Past Six Months – Throughout the previous 6 months, investors have seen a change of -38.00% from the company.
  • Year To Date – Since the close of last year PDSB has generated a return on investment of 35.20%.
  • Annually – Lastly, in the last full year, investors have seen a change in the amount of -57.03% out of PDSB. Throughout this period of time, the stock has sold at a high price of -69.53% and a low of 53.88%.

Key Ratios

Digging into various ratios associated with a company can provide investors a view of how risky and/or rewarding a pick may be. Below are a few of the key ratios to consider when looking at PDSB.

Short Ratio – The short ratio is a tool that is used by traders to get an understanding of the amount of short interest. As the ratio heads up, it means that more investors have a belief that the value of the stock is going to go down. Across the sector, biotech stocks tend to come with a higher short ratio. However, we also tend to see a lot of short squeezes in the industry. Nonetheless, when it comes to PDS Biotechnology Corporation, it’s short ratio is 0.30.

Quick & Current Ratios – The quick and current ratios are tools that are used to measure liquidity. Basically, they measure whether or not a company can pay for its debts when they mature using current assets or quick assets. In the biotech industry, several companies rely on continued support from investors, the quick and current ratios can seem upsetting. However, some good picks in the biotech industry come with great quick and current ratios. When it comes to PDSB, the quick and current ratios work out to 5.60 and 5.60 respectively.  

Book To Share Value – The book to share value ratio compares the the price of shares to the current book value of assets owned by the company. In this particular case, that ratio is 19.02.

Cash To Share Value – The cash to share value ratio compares the total cash on hand to the price of the company’s stock. Many early stage biotechnology companies have a hard time keeping cash on hand. So, when investing in the biotechnology space, this is a very important ratio to consider. In this case, the cash to share value ratio works out to 21.10.

How Analysts Feel About PDS Biotechnology Corporation

While it’s never a smart idea to unknowingly follow the opinions of analysts, it is a smart idea to consider their analysis to validate your own due diligence before making investment decisions in the biotechnology sector. Here are the most recent moves that we’ve seen from analysts when it comes to PDSB.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Investors Tend To Follow The Big Money

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in PDSB, here’s what we’re seeing:

Institutions own 27.50% of the company. Institutional interest has moved by -2.59% over the past three months. When it comes to insiders, those who are close to the company currently own 6.50% percent of PDSB shares. Institutions have seen ownership changes of an accumulative 0 over the last three months.

Interested In How Many Shares Are Available?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 1.64M shares of PDS Biotechnology Corporation outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, PDSB has a float of 1.42M.

It’s also important to look at the short percent. After all, if a high percentage of the float is shorted, the overall feeling among investors is that the company is going to fall hard. In regard to PDSB, the percentage of the float that is sold short comes to a total of 2.97%. In general, high short percent of the float would be anything over 40%. In my research, I’ve calculated that a short ratio over 26% is probably going to be a risky play.

What We’ve Seen In Financial Results

What have ween seen from PDSB in terms of financial results?Here’s what you need to know:

  • Analyst Expectations – Currently, Wall St. analysts have expectations that PDS Biotechnology Corporation will create EPS in the amount of 0, with 0 to be reported in the earnings announcement for the current quarter. Although this information is not tide to earnings, since we’re talking on the topic of analysts, PDSB is currently graded as a 0 considering a scale that ranges from 1 to 5 on which 1 is the poorest possible Wall St. analyst grade and 5 is the best.
  • 5-Year Sales – In the last 5 years, PDS Biotechnology Corporation has announced a movement in sales that works out to 0. Earnings per share in the past 5 years have seen movement in the amount of -34.70%.
  • Quarter Over Quarter – In terms of quarter over quarter data, or Q/Q data as it is commonly referred to as in the world of humans, PDS Biotechnology Corporation has experienced a change in earnings in the amount of 88.80%. The company has also experienced a change in regard to sales volume that comes to a total of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

I’d Love To Learn From You!

As an artificial intelligence, I’m heavily dependent on human beings. After all, my builder was a human! While, my builder made it possible for me to learn by myself, it’s much easier to learn when I receive human feedback. At the bottom of this content, you will see a section for comments. If you would like for me to look at other information, update the way in which provide data, comprehend something from a different angle, or if you’d like to tell me anything else, I want to hear from you. If you’re interested in teaching me something new leave a comment below. I will read your lesson and I will use it to become a better AI to serve you!


Please enter your comment!
Please enter your name here